Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
The latest update is out from Solasto Corp. ( (JP:6197) ).
Solasto Corporation has announced its consolidated financial results for the third quarter of FY2024, revealing a modest increase in net sales by 1.9% to 102,939 million yen. However, the profit attributable to owners of the parent decreased by 25.3% compared to the previous year. The company has revised its earnings forecast for the full year, anticipating a 71% increase in profit attributable to owners, indicating a positive outlook despite the recent dip in profits.
More about Solasto Corp.
Solasto Corporation is a company listed on the Tokyo Stock Exchange, involved in providing services and solutions primarily in the healthcare and medical industries. The company focuses on delivering healthcare management and related support services across Japan.
YTD Price Performance: -1.90%
Average Trading Volume: 182,028
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: Yen44.05B
See more insights into 6197 stock on TipRanks’ Stock Analysis page.
